Clinical trials have shown semaglutide use can lead to weight reductions of 14.9% to 17.4% in individuals without diabetes (Wilding et al., 2023)
Side effects are usually nonspecific and may include soft stool, mild nausea, or reduced appetiteoften related to the product form or added ingredients rather than glutathione itself
doi:10.1002/jcsm.13213 Pickart L, Vasquez-Soltero JM, Margolina A
As per the general manifestation, since its minor items were closer to constitutional symptoms, such as myalgia, arthralgia/arthritis, fever, and weight loss, rather than those limited to a specific organ (Mukhtyar et al., 2009), this subgroup analysis was not sufficient to explain the inverse correlation between serum GPX-3 concentration and BVAS